Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

GNLX - Genelux Corp

IEX Last Trade
2.14
0.160   7.477%

Share volume: 387,626
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$1.98
0.16
8.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
23%
Profitability 25%
Dept financing 9%
Liquidity 60%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.98%
1 Month
3.33%
3 Months
-18.11%
6 Months
-70.91%
1 Year
-91.28%
2 Year
-64.72%
Key data
Stock price
$2.14
P/E Ratio 
-2.82
DAY RANGE
N/A - N/A
EPS 
-$0.97
52 WEEK RANGE
$1.60 - $30.44
52 WEEK CHANGE
-$0.91
MARKET CAP 
74.942 M
YIELD 
N/A
SHARES OUTSTANDING 
34.535 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
1.91
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$200,978
AVERAGE 30 VOLUME 
$132,236
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news